Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Common Equity (2017 - 2026)

Inspire Medical Systems' Common Equity history spans 10 years, with the latest figure at $792.3 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 24.63% to $792.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $792.3 million, a 24.63% increase, with the full-year FY2025 number at $781.2 million, up 13.26% from a year prior.
  • Common Equity hit $792.3 million in Q1 2026 for Inspire Medical Systems, up from $781.2 million in the prior quarter.
  • Over the last five years, Common Equity for INSP hit a ceiling of $792.3 million in Q1 2026 and a floor of $225.1 million in Q1 2022.
  • Historically, Common Equity has averaged $572.7 million across 5 years, with a median of $589.0 million in 2024.
  • Biggest five-year swings in Common Equity: skyrocketed 133.21% in 2023 and later fell 4.32% in 2025.
  • Tracing INSP's Common Equity over 5 years: stood at $496.0 million in 2022, then rose by 15.42% to $572.5 million in 2023, then rose by 20.47% to $689.7 million in 2024, then rose by 13.26% to $781.2 million in 2025, then rose by 1.43% to $792.3 million in 2026.
  • Business Quant data shows Common Equity for INSP at $792.3 million in Q1 2026, $781.2 million in Q4 2025, and $666.5 million in Q3 2025.